Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6610 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-04-04 (tradingview.com)
Hope for Vietnam deal drives shoe and fashion shares- news
The stock exchange ticker follows important price movements on the international financial markets and their causes: 6.35 p.m.-The shares of US shoe and fashion companies turn into the plus after President Donald Trump has declared that Vietnam's president has a reduction in tariffs to US imports ...
Read more
2025-04-04 (benzinga.com)
Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks - Alnylam Pharmaceuticals (NASDAQ:ALNY), Amgen (NASDAQ:AMGN) -
Trump's new tariff move may raise U.S. pharma costs, with analysts warning of risks tied to EU manufacturing and shifting healthcare policies.
Read more
2025-03-29 (boerse-global.de)
Biogen stock: the doldrum continues? -
The biopharmaceutical company moves in difficult waters between impending US tariffs on Irish production and hopeful advances with leqembi therapy
Read more
2025-01-01 (bloombergtax.com)
Biogen Says Its US Manufacturing Will Limit Tariff Impacts (2)
Biogen Inc.'s chief executive officer said that the impact from US tariffs will be limited, as three-quarters of its product revenue comes from drugs made in the US.
Read more
2020-05-25 (trans.info)
New leader in the "Supply Chain Top 25" Ranking | .info
New leader in the "Supply Chain Top 25" Ranking
Read more